Dr Mary Kerr
Chief Executive Officer
Mary joined NeRRe Therapeutics as CEO in 2015. Before joining NeRRe Mary held a range of senior leadership roles in the pharmaceutical industry having spent the majority of her career on the R&D/commercial interface in global strategy and regional operational roles, predominantly in the specialty and orphan space. She was a founding member of the executive team of ViiV Healthcare (the independent, HIV company that combines the HIV expertise of GSK, Pfizer Inc. and Shionogi) where she led, revitalised and grew the business throughout Europe.
Mary was also previously Senior Vice President and Global Franchise Head at GSK. Mary also currently serves as CEO of KaNDy Therapeutics and is a non-executive independent director at Galapagos NV.
Mary gained a PhD in Pharmacology at the University of Bradford, did post-doctoral research at the Michigan Cancer Foundation, Detroit and has an MBA from the University of Kingston.